Anti-PD-1 antibodies and methods of use thereof
Abstract:
The present invention provides antagonizing antibodies that bind to programmed cell death protein 1 (PD-1) and methods of using same. The anti-PD-1 antibodies can be used therapeutically alone or in combination with other therapeutics to treat cancer and other diseases.
Public/Granted literature
Information query
Patent Agency Ranking
0/0